Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA.
Departments of Pediatrics and Psychology, The Ohio State University, Columbus, OH, USA.
Support Care Cancer. 2021 Feb;29(2):1121-1128. doi: 10.1007/s00520-020-05612-9. Epub 2020 Jul 9.
Many children receiving chemotherapy struggle with therapy-induced side effects. To date, there has been no literature investigating the needs, knowledge, or implementation of osteopathic manipulative treatments (OMT) as a supportive care option in pediatric oncology. We hypothesized that pediatric oncology clinicians, caregivers, and patients have (a) limited knowledge of OMT and (b) dissatisfaction with current supportive care options and (c) would be interested in having OMT available during chemotherapy, once educated.
Participants included three cohorts: (1) children aged ≥ 9 years, diagnosed with cancer and actively receiving chemotherapy; (2) their caregivers; and (3) oncology clinicians at Nationwide Children's Hospital. Participants completed 1:1 semi-structured interviews, which were audio-recorded, transcribed, and analyzed for thematic content regarding their perception of supportive care measures and views on OMT. Quantitative data was summarized descriptively.
A total of 60 participants completed the interview. Participants demonstrated limited awareness of osteopathic medicine; no participant had more than "some" knowledge of OMT. After education about OMT using a brief video, all clinicians, caregivers, and 95% of patients were receptive to OMT as a supportive care option. Major themes included the following: (a) patients have uncontrolled chemotherapy side effects, (b) improved supportive care options are desired, and (c) osteopathic medicine is a favorable supportive care adjunct.
Pediatric oncology clinicians, caregivers, and patients reported a need for better management of chemotherapy-associated side effects and an interest in utilizing OMT. These findings support further investigation into the safety, feasibility, and efficacy of implementing OMT in the pediatric oncology clinical setting.
许多接受化疗的儿童都在与治疗引起的副作用作斗争。迄今为止，尚无文献研究过整骨治疗（OMT）作为儿科肿瘤学支持性护理选择的需求、知识或实施情况。我们假设儿科肿瘤学临床医生、护理人员和患者（a）对 OMT 的了解有限，（b）对当前支持性护理选择不满意，（c）一旦接受教育，他们会有兴趣在化疗期间提供 OMT。
参与者包括三个队列：（1）年龄≥9 岁、被诊断患有癌症且正在接受化疗的儿童；（2）他们的护理人员；（3）全国儿童医院的肿瘤学临床医生。参与者完成了 1:1 的半结构化访谈，访谈内容被录音、转录，并进行了主题内容分析，以了解他们对支持性护理措施的看法以及对 OMT 的看法。定量数据以描述性方式进行总结。
共有 60 名参与者完成了访谈。参与者对整骨医学的认识有限；没有参与者对 OMT 有“一些”以上的了解。在使用简短视频进行 OMT 教育后，所有临床医生、护理人员和 95%的患者都愿意接受 OMT 作为支持性护理选择。主要主题包括以下几点：（a）患者有不受控制的化疗副作用，（b）需要更好的支持性护理选择，（c）整骨医学是一种受欢迎的支持性护理辅助手段。
儿科肿瘤学临床医生、护理人员和患者报告称，需要更好地管理与化疗相关的副作用，并对使用 OMT 感兴趣。这些发现支持进一步研究在儿科肿瘤学临床环境中实施 OMT 的安全性、可行性和疗效。
